Author | Dhanya K. Nambiar, PhD | OncLive

Author | Dhanya K. Nambiar, PhD

Articles

The Detection of Galectin-1 in Head and Neck Cancer

May 29, 2017

Dhanya K. Nambiar, PhD, Stanford University, discusses the detection of Galectin-1 for patients with head and neck cancer.

Rationale for Targeting Galectin-1 in Head and Neck Cancer

May 04, 2017

Dhanya K. Nambiar, PhD, Stanford University, explains the rationale behind targeting Galectin-1 (Gal-1) in head and neck cancer.

Dr. Nambiar on Next Steps with Galectin-1 for Head and Neck Cancer

April 21, 2017

Dhanya K. Nambiar, PhD, Stanford University, discusses the next steps with targeting galectin-1 with radiation therapy and immune checkpoint inhibitors in patients with head and neck cancer.

Targeting Galectin-1 With Radiation and Immune Checkpoints in Head and Neck Cancer

April 07, 2017

Dhanya K. Nambiar, PhD, Stanford University, discusses targeting galectin-1 with radiation therapy and immune checkpoint inhibitors in head and neck cancer.

x